(Q43540659)

24 November 2017

title

The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys (English)

1 reference

24 November 2017

0 references

van Heek M

1

1 reference

24 November 2017

Compton DS

series ordinal

2

1 reference

24 November 2017

Davis HR

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

European Journal of Pharmacology

24 November 2017

published in

1 reference

24 November 2017

volume

415

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

79-84

1 reference

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Postprandial lipoprotein metabolism and atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

Atherogenesis: a postprandial phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900825-1

10.1016/S0014-2999(01)00825-1

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference